Emotion Recognition and Social Cognition in JME patients
Organizational Data
- DRKS-ID:
- DRKS00011216
- Recruitment Status:
- Recruiting planned
- Date of registration in DRKS:
- 2016-10-21
- Last update in DRKS:
- 2016-10-21
- Registration type:
- Prospective
Acronym/abbreviation of the study
No Entry
URL of the study
No Entry
Brief summary in lay language
Juvenile myoclonic epilepsy (JME) is a very common form of epilepsy with a high genetic predisposition. This form of epilepsy usually begins in puberty and poor social adjustments as well as behavioral difficulties are often observed in patients with JME. Recent brain imaging studies showed that such emotional and behavioral problems are associated with structural and functional alterations of certain brain areas. However, till now, there are no neuroimaging or neuropsychological studies related to emotion processing in patients with JME with focus on limbic structures. Thus, the aim of this study is so show possible changes in emotion processing and social cognition in patients with JME from multiple aspects by using structural and functional imaging methods as well as neuropsychological and psychiatric examinations. In order to identify possible differences, the results of JME patients will be compared with the results of healthy controls as well as siblings of patients with JME. Further, newly diagnosed patients will be compared to patients who have a long-standing course of the disease. Results of this study may help to develop new psychological and pharmacological intervention strategies and further lead to a better management of social and behavioral difficulties in patients with JME.
Brief summary in scientific language
Juvenile myoclonic epilepsy (JME) is the most common age-related idiopathic generalized epilepsy with a high genetic predisposition, comprising 5-10% of all epilepsies. JME begins usually in puberty with the peak between 14 and 16 years. Poor social adjustment and behavioral disturbances, which resemble frontal lobe dysfunction, are often observed in JME. Recent studies demonstrate an elevated prevalence of psychiatric disorders in JME patients, particularly anxiety, mood, and mild to moderate cluster B personality disorders. These psychiatric disturbances contribute to incompliance of JME patients with regard to intake of antiepileptic drugs and avoidance of trigger factors of seizures. Incompliance frequently causes persistence of seizures and perpetual psychiatric problems leading to a vicious circle. In recent advanced brain imaging studies on JME patients, emotional and behavioral problems have been associated to subtle structural and functional alterations mainly in frontal cortex and thalamus. Morphological and functional abnormalities may extend beyond thalamo-cortical circuitry and involve cingulate, occipital and insular cortices as well as hippocampi and cerebellum. There is emerging evidence that patients with abnormal emotion processing and regulation, such as those with bipolar disorder, show disrupted connectivity between limbic structures and frontal cortices. There are no neuroimaging or neuropsychological studies related to emotion processing in patients with JME with focus on limbic structures. There is an unmet need of understanding of pathophysiological mechanisms of emotion dysregulation which may predispose to behavioral disturbances and poor social adjustment in JME patients. We aim to address the problem of emotional disturbances and social adjustment in JME patients from multiple aspects through thorough functional and structural assessment which would potentially enable elaboration of an unifying concept explaining neurobiological background of disturbances in emotional processing and social adjustment in JME patients. This will be achieved by (i) employing novel neuropsychological test batteries and fMRI paradigms for assessment of emotion recognition and social cognition; (ii) utilizing novel techniques for macro- and microstructural evaluation of brain structures involved in emotion recognition and social cognition and their connections with other brain areas, particularly with frontal lobes; (iii) by comparing for a first time the results of functional and structural alterations in patients with newly diagnosed versus longstanding JME in order to determine causative relationship of possible functional / structural deficits with ongoing seizure activity; (iv) by comparing functional / structural data of JME patients with similar data of their siblings and healthy controls for ascertaining whether functional / structural alterations could be specific for JME. Results of this study may potentially enable developing of psychological and pharmacological interventional strategies for managing behavioral disturbances in patients with JME.
Health condition or problem studied
- ICD10:
- G40 - Epilepsy
- Free text:
- Juvenile myoclonic epilepsy (JME)
- Healthy volunteers:
- No Entry
Interventions, Observational Groups
- Arm 1:
- Patients: Patients with juvenile myoclonic epilepsy (JME): Visit 1: psychiatric examination; Visit 2: neuropsychological testing; Visit 3: structural and functional Imaging.
- Arm 2:
- Controls I: healthy subjects: Visit 1: psychiatric examination; Visit 2: neuropsychological testing; Visit 3: structural and functional Imaging.
- Arm 3:
- Controls II: siblings of patients with JME: Visit 1: psychiatric examination; Visit 2: neuropsychological testing; Visit 3: structural and functional Imaging.
Endpoints
- Primary outcome:
- The main goal of this study is to determine structural and functional substrates of deficits in emotion processing and social cognition in patients with JME. In order to achieve the main goal we will develop the following strategies: • Psychiatric profile of JME patients as well as healthy controls and siblings of JME patients will be assessed. JME patients will thereafter be divided into two groups: those with and without Axis I and/or II psychiatric disorders according to DSM IV criteria. • Emotion processing and social cognition will be assessed by means of specific neuropsychological tests in patients with JME as well as healthy controls and siblings of JME patients. Those tests compose various tests to examine (i) emotion recognition (Facial Expressions of Emotion: Stimuli and Tests (FEEST), Empathy Quotient (EQ)), (ii) Theory of Mind (ToM) tests (Reading the Mind in the Eyes Test, Moving Triangles, Faux Pas Test), (iii) tests to examine executive functions (Wechsler Intelligence Scale for Adults and Children, Wisconsin Card Sorting Test (WCTS), Trail Making Test A & B (TMT A & B), Regensburger Wortflüssigkeitstest (RWT), Toronto-Alexithymia Scale (TAS-26)) as well as (iv) a self-report questionnaire to examine depression and anxiety symptoms (Hospital Anxiety and Depression Scale (HADS-D)). • Morphological and functional imaging assessment (magnetic resonance imaging (MRI) and functional magnetic resonance imaging (fMRI)) of limbic structures in two groups of JME patients (with and without Axis I and/or II psychiatric disorders) as well as healthy controls andsiblings of JME patients will be performed. • Imaging and neuropsychological data in two groups of JME patients (with and without Axis I and/or II psychiatric disorders) as well as with the similar data of healthy controls and siblings of JME patients will be compared. • Imaging and neuropsychological data of two groups of JME patients: those with newly manifested JME (maximum disease duration 3 years) and those with longstanding JME (disease duration over 3 years) as well as with the similar data of healthy controls and siblings of JME patients will be compared.
- Secondary outcome:
- No Entry
Study Design
- Purpose:
- Other
- Retrospective/prospective:
- No Entry
- Study type:
- Non-interventional
- Longitudinal/cross-sectional:
- No Entry
- Study type non-interventional:
- No Entry
Recruitment
- Recruitment Status:
- Recruiting planned
- Reason if recruiting stopped or withdrawn:
- No Entry
Recruitment Locations
- Recruitment countries:
-
- Austria
- Number of study centers:
- Multicenter study
- Recruitment location(s):
-
- University medical center Abteilung für Neurologie Salzburg
- University medical center Abteilung für Neurologie Innsbruck
Recruitment period and number of participants
- Planned study start date:
- 2016-11-01
- Actual study start date:
- No Entry
- Planned study completion date:
- No Entry
- Actual Study Completion Date:
- No Entry
- Target Sample Size:
- 200
- Final Sample Size:
- No Entry
Inclusion Criteria
- Sex:
- All
- Minimum Age:
- 14 Years
- Maximum Age:
- no maximum age
- Additional Inclusion Criteria:
- Inclusion criteria for patients: - Electro-clinical diagnosis of JME based on Classification of the International League against Epilepsy - Patients aged 14 years or older with willingness to participate in the project (informed consent will be obtained from all patients and/or parents of paediatric patients aged between 14 and 18 years) - Patients with ability to participate in MRI and fMRI studies Inclusion criteria for controls (healthy subjects and siblings of patients with JME): - Healthy subjects and siblings of patients with JME aged 18 years or older with willingness to participate in the study
Exclusion Criteria
Exclusion criteria for patients: - Occurrence of epileptic seizure <72 hours prior to MRI &fMRI study - Patients with medical and/ or neurological illnesses other than JME (except for cluster B psychiatric disorders) - Intake of Topiramate and / or Benzodiazepine - Structural lesion on MRI - Incompatibility with MRI investigation - Pregnancy Exclusion criteria controls (healthy subjects and siblings of patients with JME):: - Individuals with medical and/ or neurological illnesses - Individuals with EEG abnormalities (applies to siblings of patients with JME. All of them will undergo routine EEG) - Structural lesion on MRI - Incompatibility with MRI investigation - Pregnancy
Addresses
Primary Sponsor
- Address:
- Universitätsklinik für Neurologie der Paracelsus medizinischen Privatuniversität SalzburgUniv.-Prof. Dr. Mag. Eugen TrinkaIgnaz-Harrer-Str. 795020 SalzburgAustria
- Telephone:
- +43 (0) 5 7255 30200
- Fax:
- +43 (0) 5 7255 30399
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.salk.at/107.html
- Investigator Sponsored/Initiated Trial (IST/IIT):
- Yes
Contact for Scientific Queries
- Address:
- Universitätsklinik für Neurologie der Paracelsus medizinischen Privatuniversität SalzburgUniv.-Prof. Dr. Mag. Eugen TrinkaIgnaz-Harrer-Str. 795020 SalzburgAustria
- Telephone:
- +43 (0) 5 7255 30200
- Fax:
- +43 (0) 5 7255 30399
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.salk.at/107.html
Contact for Public Queries
- Address:
- Universitätsklinik für Neurologie der Paracelsus medizinischen Privatuniversität SalzburgMag. Elisabeth SchmidIgnaz-Harrer-Str. 795020 SalzburgAustria
- Telephone:
- +43 (0) 5 7255 56788
- Fax:
- +43 (0) 5 7255 34899
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.salk.at/107.html
Principal Investigator
- Address:
- Universitätsklinik für Neurologie der Paracelsus medizinischen Privatuniversität SalzburgUniv.-Prof. Dr. Mag. Eugen TrinkaIgnaz-Harrer-Str. 795020 SalzburgAustria
- Telephone:
- +43 (0) 5 7255 30200
- Fax:
- +43 (0) 5 7255 30399
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.salk.at/107.html
Sources of Monetary or Material Support
Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)
- Address:
- Fonds zur Förderung der wissenschaftlichen Forschung (FWF)Haus der ForschungSensengasse 11090 WienAustria
- Telephone:
- +43-1-505 67 40
- Fax:
- +43-1-505 67 39
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.fwf.ac.at
Private sponsorship (foundations, study societies, etc.)
- Address:
- Paracelsus Medizinische Privatuniversität SalzburgStrubgasse 215020 SalzburgAustria
- Telephone:
- +43 (0) 662 24200
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://http:/www.pmu.ac.at
Ethics Committee
Address Ethics Committee
- Address:
- Amt der Salzburger Landesregierung Ethikkommission für das Bundesland Salzburg [Amt der Salzburger Landesregierung, Ethikkommission für das Bundesland Salzburg]Sebastian-Stief-Gasse 2, Postfach 5275020 SalzburgAustria
- Telephone:
- No Entry
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- https://www.salzburg.gv.at/dienststellen/abteilungen/209/20901/415/ethikkommission
Vote of leading Ethics Committee
- Vote of leading Ethics Committee
- Date of ethics committee application:
- 2013-06-06
- Ethics committee number:
- 1638
- Vote of the Ethics Committee:
- Approved
- Date of the vote:
- 2013-06-26
Further identification numbers
- Other primary registry ID:
- No Entry
- EudraCT Number:
- No Entry
IPD - Individual Participant Data
- Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
- No Entry
- IPD Sharing Plan:
- No Entry
Study protocol and other study documents
- Study protocols:
- No Entry
- Study abstract:
- No Entry
- Other study documents:
- No Entry
- Background literature:
- No Entry
- Related DRKS studies:
- No Entry
Publication of study results
- Planned publication:
- No Entry
- Publikationen/Studienergebnisse:
- No Entry
- Date of first publication of study results:
- No Entry
- DRKS entry published for the first time with results:
- No Entry
Basic reporting
- Basic Reporting / Results tables:
- No Entry
- Brief summary of results:
- No Entry